- Lobbying
- amylin
Lobbying Arrangements Results for 'Amylin'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details General Healthcare and Medical Device Issues |
Amylin
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details S. 2029, Physician Payments Sunshine Act of 2007, provisions relating to or impacting pharmaceuticals. Other legislation relating to or impacting pharmaceuticals. |
Amylin Pharmaceuticals, Inc.
|
ALSTON & BIRD, LLP | |||
Details Coverage and reimbursement for diabetes and related conditions |
Amylin Pharmaceuticals
pharmaceutical company |
HillCo Partners | |||
Details General FDA, pharmaceutical, and Medicare issues. |
Amylin Pharmaceuticals, Inc.
|
COMPASS CONSULTING GROUP, LLC | |||
Details Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026 Issues relating to Medicare... |
AMYLIN PHARMACEUTICALS
|
in-house lobbying | |||
Details General representation |
Amylin Pharmaceuticals
Pharmaceutical Company |
MEHLMAN VOGEL CASTAGNETTI, INC. | |||
Details Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act.S... |
Bristol-Myers Squibb
|
PODESTA GROUP, INC. | |||
Details H.R. 1038, Access to Life-Saving Medicine Act H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007 H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505, Afford... |
AMYLIN
|
MEHLMAN VOGEL CASTAGNETTI, INC. |